Companies / Skye Bioscience, Inc.
Skye Bioscience, Inc.
Nasdaq: SKYECIK 1516551SAN DIEGO, CA
Financials
Ownership
35.1M shares outstanding · as of May 8, 2026
Ownership
| Institutions | 45.88% | 16,124,740 |
| Public float | 54.12% | 19,018,982 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 11
View all →| Insider | % of shares | Shares |
|---|---|---|
Arora Puneet S.FormerChief Medical Officer | — | — |
Arsenault KaitlynChief Financial Officer | — | — |
Charych Deborah H.Director | — | — |
Dhillon PunitCEOChief Executive Officer · Director | — | — |
Diep Tuan TuFormerChief Development Officer | — | — |
Grayson Paul A.Director | — | — |
Jenkins AnnalisaDirector | — | — |
Schwab Andrew J.Director | — | — |
Sharp John PFormerChief Financial Officer | — | — |
Smith Karen L.Director | — | — |
Institutional holders 50
View all →| Holder | Value | % of shares |
|---|---|---|
| $7.26M | 27.55% | |
| $1.51M | 5.71% | |
| $968.1K | 4.48% | |
| $662.1K | 2.51% | |
| $359.1K | 1.36% | |
| $170.4K | 0.79% | |
| $161.5K | 0.66% | |
| $158.7K | 0.73% | |
| $143.3K | 0.66% | |
| $70.0K | 0.27% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2024 as of | Barclays PLC 13F manager | New | Common Stock | $339.1K | +42K | 42,338 0.12% of shares | low |
| Q1 2025 as of | Barclays PLC 13F manager | Trim | Common Stock | $-78.9K | -50K -71.26% | 20,006 0.06% of shares | low |
| Q1 2026 as of | Baker Bros. Advisors LP 13F manager | Add | Common Stock | $76.6K | +125K +8.59% | 1,575,243 4.48% of shares | low |
| Q1 2026 as of | Millennium Management LLC 13F manager | Trim | Common Stock | $-75.2K | -122K -32.14% | 258,200 0.73% of shares | low |
| Q3 2024 as of | Barclays PLC 13F manager | Add | Common Stock | $60.8K | +16K +36.73% | 57,889 0.16% of shares | low |
| Q1 2026 as of | Geode Capital Management, LLC 13F manager | Add | Common Stock | $41.3K | +67K +31.93% | 277,256 0.79% of shares | low |
| Q2 2026 as of | BlackRock, Inc. 13F manager | Trim | Common Stock | $-33.9K | -49K -17.37% | 232,874 0.66% of shares | low |
| Q4 2024 as of | Barclays PLC 13F manager | Add | Common Stock | $33.2K | +12K +20.26% | 69,620 0.20% of shares | low |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| SKYE | Common Stock | 83086J200 |